Surgical Quality Improvement

Cystectomy Outcomes

Cystectomy ACS NSQIP Outcomes

January 1, 2024 – December 31, 2024

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s cystectomy ACS NSQIP performance benchmarked against 108 participating sites.

Cystectomy (108 Sites)NObservedExpected
30 Day Morbidityᵇ15513.55%24.85%
Cardiac1550.65%1.76%
Pneumonia1550.65%2.11%
Unplanned Intubation1551.94%1.54%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus1551.29%3.17%
Renal Failure1557.10%6.43%
Urinary Tract Infection (UTI)1550.65%3.07%
Surgical Site Infection (SSI)1558.39%12.25%
Sepsis1556.45%8.68%
C.diff Colitis1555.81%2.35%
Length of Stay13213.64%17.03%
Unplanned Readmission15520.65%21.91%
Anastomotic Leak1552.58%1.70%
Rectal Injury1550.65%1.21%
Prolonged NPO/NGT Useᵃ15526.45%17.42%
Ureteral Obstructionᵇ1550.00%3.87%
Lymphocele/Leak/Fluid1550.00%3.62%

American College of Surgeons National Surgical Quality Improvement Program, 2025.
ACS NSQIP® Semiannual Report July, 2025, Chicago: American College of Surgeons.

ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.

ᵇIdentified as a statistical outlier (lower than expected) by the ACS NSQIP hierarchical model.